Research Article
Safety, Tolerability, Pharmacokinetics, and Efficacy of Terlipressin Delivered by Continuous Intravenous Infusion in Patients with Cirrhosis and Refractory Ascites
Table 3
Summary of terlipressin PK parameters.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CL: clearance; %CV: percent coefficient of variation; K: elimination rate constant; : half-life; V: volume of distribution. |